More about

Queen's University

News
October 24, 2023
2 min read
Save

Immersive virtual reality reduces cancer-related pain, distress

Virtual reality interventions can serve as acceptable treatments with the potential to improve both physical and psychological consequences of certain long-term illnesses, according to a study published in BMJ Supportive & Palliative Care.

News
October 10, 2023
2 min read
Save

Remote ICD deactivation feasible in patients receiving comfort-based end-of-life care

Remote deactivation of implantable cardioverter defibrillators was successful in patients transitioned to end-of-life care, with patients and family reporting high satisfaction with the protocol, researchers reported.

News
August 14, 2023
4 min read
Save

Cancer trial toxicity reporting inconsistent, often uses ‘subjective minimizing language’

Abstracts of randomized phase 3 clinical trials in gastrointestinal oncology frequently use subjective minimizing language to characterize serious toxicities, according to results of a systematic review presented at ASCO Annual Meeting.

News
March 28, 2023
2 min read
Save

Healthy plant-based diets lower risks for mortality, major chronic conditions

Middle-aged adults with greater adherence to a healthful plant-based diet had significantly lower risks for CVD, cancer and mortality than those who had lower adherence, according to study results published in JAMA Network Open.

News
October 18, 2022
2 min read
Save

Age, other factors linked to delays in melanoma diagnosis

GENEVA — Factors such as age and comorbidities appeared associated with longer time to melanoma diagnosis, according to study results presented at World Cancer Congress.

News
May 24, 2022
2 min read
Save

‘Game changer’ vaccine for recurrent UTIs improves patients’ quality of life

A vaccine for recurrent UTIs significantly reduced UTI episodes and a need for health care resources, reducing “the personal burden” of disease, according to researchers.

News
October 05, 2021
2 min read
Save

‘Broken’ system: Labels, guidelines include cancer drugs that failed confirmatory trials

Indications for which cancer drugs receive accelerated approval often remain on drug labeling after confirmatory trials show no improvement in the primary efficacy endpoint, results of a retrospective, observational study showed.